Position in MRK
as of Jun 30, 2026
· filed Jul 10, 2026
Position Value
$5,836,470
+$498,121 QoQ
Shares Held
45,420
+2.3% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
1.37%
of 13F equity value
Holder Rank
#973
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Whitener Capital Management, Inc. holds $31,660,073 across 7 Drug Manufacturers - General names. MRK ranks #3 (18.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
41,935 | $10,552,523 | |
| 2 | JNJ |
Johnson & Johnson
|
26,121 | $6,633,950 | |
| 3 | MRK |
Merck & Co., Inc.
This page
|
45,420 | $5,836,470 | |
| 4 | LLY |
ELI LILLY & Co
|
2,960 | $3,550,313 | |
| 5 | AMGN |
Amgen Inc
|
5,665 | $2,051,409 | |
| 6 | PFE |
Pfizer Inc
|
82,959 | $1,997,652 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
8,214 | $1,037,756 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,836,470 | 45,420 | Shares | Sole | 2026-07-10 | |
| 2026-03-31 | $5,338,349 | 44,379 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $4,689,438 | 44,551 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $3,392,534 | 40,421 | Shares | Sole | 2025-10-15 | |
| 2025-06-30 | $3,133,706 | 39,587 | Shares | Sole | 2025-07-14 | |
| 2025-03-31 | $3,496,421 | 38,953 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $4,029,238 | 40,503 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $4,576,808 | 40,303 | Shares | Sole | 2024-10-29 | |
| 2024-06-30 | $5,040,393 | 40,714 | Shares | Sole | 2024-07-17 | |
| 2024-03-31 | $5,160,960 | 39,113 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $4,321,552 | 39,640 | Shares | Sole | 2024-01-10 | |
| 2023-09-30 | $4,165,871 | 40,465 | Shares | Sole | 2023-11-02 | |
| 2023-06-30 | $4,727,066 | 40,966 | Shares | Sole | 2023-07-13 | |
| 2023-03-31 | $4,356,138 | 40,945 | Shares | Sole | 2023-04-12 | |
| 2022-12-31 | $4,696,957 | 42,334 | Shares | Sole | 2023-03-01 | |
| 2022-09-30 | $3,736,230 | 43,384 | Shares | Sole | 2022-10-28 | |
| 2022-06-30 | $3,912,560 | 42,915 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $3,522,406 | 42,930 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $3,309,315 | 43,180 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $2,344,333 | 31,212 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $3,014,598 | 38,763 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $2,559,312 | 33,199 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $2,553,140 | 31,212 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $2,038,414 | 24,574 | Shares | Sole | 2020-10-09 | |
| 2020-06-30 | $1,706,983 | 22,074 | Shares | Sole | 2020-07-17 | |
| 2020-03-31 | $1,673,752 | 21,754 | Shares | Sole | 2020-04-24 | |
| No filing history on record for this holder in this stock. | ||||||